Evidence map›Paper›PMID 25211669›Full record

ArticleChemical research in toxicology2014

Protein modification by adenine propenal.

Sarah C Shuck, Orrette R Wauchope, Kristie L Rose, Philip J Kingsley, Carol A Rouzer, Steven M Shell, Norie Sugitani, Walter J Chazin, Irene Zagol-Ikapitte, Olivier Boutaud and 4 more

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Sarah C ShuckA. B. Hancock Jr. Memorial Laboratory for Cancer Research, Departments of Biochemistry, ‡Chemistry, and §Pharmacology, ∥Mass Spectrometry Research Center, ⊥Center in Molecular Toxicology, #Center for Structural Biology, ∇Department of Medicine, Vanderbilt Institute of Chemical Biology, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine , Nashville, Tennessee 37232-0146, United States.
Orrette R Wauchope
Kristie L Rose
Philip J Kingsley
Carol A Rouzer
Steven M Shell
Norie Sugitani
Walter J Chazin
Irene Zagol-Ikapitte
Olivier Boutaud
John A Oates
James J Galligan
William N Beavers
Lawrence J Marnett
Vanderbilt University · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WALTER J. CHAZIN · 2001 to 2026
$89.6M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 1986 to 2011
$28.1M
Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
THE PHARMACOLOGY OF INHIBITORS OF HEME PROTEIN-CATALYZED LIPID PEROXIDATIONP50GM015431 · NIGMS · VANDERBILT UNIVERSITY · PI CAPRIOLI, RICHARD M · 1985 to 2010
$15.0M
Therapeutic Modulation of Endothelial Cell TetrahydrobiopterinP01GM015431 · NIGMS · VANDERBILT UNIVERSITY · PI ROBERTS, JACKSON L · 2011 to 2015
$9.5M
BIOCHEMICAL &CHEMICAL TRAINING FOR CANCER RESEARCHT32CA009582 · NCI · VANDERBILT UNIVERSITY · PI David K Cortez · 1987 to 2026
$8.8M
Chemistry and Biology of Malondialdehyde DNA AdductsR37CA087819 · NCI · VANDERBILT UNIVERSITY · PI MARNETT, LAWRENCE J. · 2005 to 2014
$4.2M
ACQUISITION OF A 500 MHZ LC-NMR: PEPTIDE CHEMISTRYS10RR019022 · NCRR · VANDERBILT UNIVERSITY · PI RIZZO, CARMELO J · 2005 to 2005
$500k
Elucidating the Chemistry and Targets of Cross-linking by Endogenous DNA DamageF32CA159701 · NCI · VANDERBILT UNIVERSITY · PI SHUCK, SARAH C. · 2011 to 2013
$139k
NCI NIH HHS F32 CA159701-01NCI NIH HHS P01 CA092584NCI NIH HHS R37 CA087819NCI NIH HHS T32 CA009582NCRR NIH HHS S10 RR019022NIDDK NIH HHS DK020593NIDDK NIH HHS P30 DK020593NIEHS NIH HHS P30 ES000267NIEHS NIH HHS R01ES1065561NIEHS NIH HHS T32 ES007028NIGMS NIH HHS GM15431NIGMS NIH HHS P01 GM015431
6 · The paper itself

Abstract

Base propenals are products of the reaction of DNA with oxidants such as peroxynitrite and bleomycin. The most reactive base propenal, adenine propenal, is mutagenic in Escherichia coli and reacts with DNA to form covalent adducts; however, the reaction of adenine propenal with protein has not yet been investigated. A survey of the reaction of adenine propenal with amino acids revealed that lysine and cysteine form adducts, whereas histidine and arginine do not. N(ε)-Oxopropenyllysine, a lysine-lysine cross-link, and S-oxopropenyl cysteine are the major products. Comprehensive profiling of the reaction of adenine propenal with human serum albumin and the DNA repair protein, XPA, revealed that the only stable adduct is N(ε)-oxopropenyllysine. The most reactive sites for modification in human albumin are K190 and K351. Three sites of modification of XPA are in the DNA-binding domain, and two sites are subject to regulatory acetylation. Modification by adenine propenal dramatically reduces XPA's ability to bind to a DNA substrate.

Indexed as

AdenineAmino Acid SequenceChromatography, High Pressure LiquidCysteineFluorescence PolarizationHumansLysineMolecular Sequence DataPeptidesSerum AlbuminTandem Mass SpectrometryXeroderma Pigmentosum Group A Protein9-(3-oxoprop-1-enyl)adenineAdenineCysteineLysinePeptidesSerum AlbuminXeroderma Pigmentosum Group A Protein

Identifiers

PMID25211669
PMCPMC4203390
OpenAlexW2326371948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.